Antisense Therapeutics (ASX: ANP) – Webinar Presentation

By Company News | More Articles by Company News

Mark Diamond – Managing Director and CEO –  Antisense Therapeutics is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.

RELATED COMPANIESTagged